NCT02339740
Clinical Trial Information
Trial Number: NCT02339740 (ClinicalTrials.gov)
Disease Type:
- Hematopoietic Neoplasm/Leukemia - Acute Myeloid Leukemia
Trial Title:
A Phase III Study for Patients with Newly Diagnosed Acute Promyelocytic Leukemia (APL) using Arsenic Trioxide and All-Trans Retinoic Acid
Study ID:
AAML1331
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
Title | Description |
---|---|
NCT02339740-D2 | NCT02339740-D2: There are 2 datasets associated with the PMID 34762093: NCT02339740-D1 through NCT02339740-D2. This dataset, NCT02339740-D2, is an adverse event level dataset (single row per adverse event, period, and patient) containing information of the adverse events of interest by period in the AAML1331 clinical trial. Data for this publication’s historical control, AAML0631, can be found in NCT00866918-D1 and NCT00866918-D2. |
NCT02339740-D1 | NCT02339740-D1: There are 2 datasets associated with the PMID 34762093: NCT02339740-D1 through NCT02339740-D2. This dataset, NCT02339740-D1 containing patient characteristics, laboratory findings, and outcome for eligible Acute Promyelocytic Leukemia in children enrolled on the AAML1331 clinical trial. Data for this publication’s historical control, AAML0631, can be found in NCT00866918-D1 and NCT00866918-D2. |
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®